Evidence map›Paper›PMID 35029517›Full record

Observational studyRadiology. Imaging cancer2022

Accelerated Breast Diffusion-weighted Imaging Using Multiband Sensitivity Encoding with the CAIPIRINHA Method: Clinical Experience at 3 T.

Debosmita Biswas, Daniel S Hippe, Yi Wang, Michaela R DelPriore, Mladen Zečević, John R Scheel, Habib Rahbar, Savannah C Partridge

Registry-linked trialOpen access · diamondAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Radiology. Imaging cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03607552 (Non-contrast DWI for Supplemental Screening of Women With Dense Breasts), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03607552 active not recruitingnot on this map

Non-contrast DWI for Supplemental Screening of Women With Dense Breasts

TypeobservationalSponsorUniversity of WashingtonRan2018 to 2029Enrolled269ConditionsBreast CancerArmsNon-contrast DWI, Non-contrast MRI
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Breast Diffusion-weighted MR Imaging: Current Applications, Insights from Screening, and Future Directions.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Review
  3. Update on DWI for Breast Cancer Diagnosis and Treatment Monitoring.AJR. American journal of roentgenology · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Debosmita BiswasFrom the Department of Radiology, University of Washington, Seattle, Wash (D.B., D.S.H., M.R.D., M.Z., J.R.S., H.R., S.C.P.); Philips Medical Systems International, Best, the Netherlands (Y.W.); and Department of Breast Imaging, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG2-200, Seattle, WA 98109 (J.R.S., H.R., S.C.P.).ORCID 0000-0002-0798-5637
Daniel S HippeFrom the Department of Radiology, University of Washington, Seattle, Wash (D.B., D.S.H., M.R.D., M.Z., J.R.S., H.R., S.C.P.); Philips Medical Systems International, Best, the Netherlands (Y.W.); and Department of Breast Imaging, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG2-200, Seattle, WA 98109 (J.R.S., H.R., S.C.P.).ORCID 0000-0003-2427-4404
Yi WangFrom the Department of Radiology, University of Washington, Seattle, Wash (D.B., D.S.H., M.R.D., M.Z., J.R.S., H.R., S.C.P.); Philips Medical Systems International, Best, the Netherlands (Y.W.); and Department of Breast Imaging, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG2-200, Seattle, WA 98109 (J.R.S., H.R., S.C.P.).
Michaela R DelPrioreFrom the Department of Radiology, University of Washington, Seattle, Wash (D.B., D.S.H., M.R.D., M.Z., J.R.S., H.R., S.C.P.); Philips Medical Systems International, Best, the Netherlands (Y.W.); and Department of Breast Imaging, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG2-200, Seattle, WA 98109 (J.R.S., H.R., S.C.P.).
Mladen ZečevićFrom the Department of Radiology, University of Washington, Seattle, Wash (D.B., D.S.H., M.R.D., M.Z., J.R.S., H.R., S.C.P.); Philips Medical Systems International, Best, the Netherlands (Y.W.); and Department of Breast Imaging, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG2-200, Seattle, WA 98109 (J.R.S., H.R., S.C.P.).ORCID 0000-0002-0437-2181
John R ScheelFrom the Department of Radiology, University of Washington, Seattle, Wash (D.B., D.S.H., M.R.D., M.Z., J.R.S., H.R., S.C.P.); Philips Medical Systems International, Best, the Netherlands (Y.W.); and Department of Breast Imaging, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG2-200, Seattle, WA 98109 (J.R.S., H.R., S.C.P.).ORCID 0000-0002-0998-0098
Habib RahbarFrom the Department of Radiology, University of Washington, Seattle, Wash (D.B., D.S.H., M.R.D., M.Z., J.R.S., H.R., S.C.P.); Philips Medical Systems International, Best, the Netherlands (Y.W.); and Department of Breast Imaging, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG2-200, Seattle, WA 98109 (J.R.S., H.R., S.C.P.).ORCID 0000-0003-4835-1478
Savannah C PartridgeFrom the Department of Radiology, University of Washington, Seattle, Wash (D.B., D.S.H., M.R.D., M.Z., J.R.S., H.R., S.C.P.); Philips Medical Systems International, Best, the Netherlands (Y.W.); and Department of Breast Imaging, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG2-200, Seattle, WA 98109 (J.R.S., H.R., S.C.P.).ORCID 0000-0001-6370-9111
Seattle Cancer Care Alliance · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment TrialsR01CA132870 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M., NEWITT, DAVID C · 2008 to 2019
$4.8M
Quantitative Imaging for Assessing Breast Cancer Response to TreatmentU01CA225427 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M. · 2018 to 2022
$3.2M
Multicenter Quantitative MRI Assessment of Breast Cancer Therapy ResponseR01CA248192 · NCI · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI WEI HUANG, James H Holmes · 2021 to 2026
$2.8M
Quantitative Imaging for Assessing Breast Cancer Response to TreatmentU01CA151235 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M. · 2011 to 2015
$2.8M
Validation and Standardization of the Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker in Breast CancerR01CA207290 · NCI · UNIVERSITY OF WASHINGTON · PI PARTRIDGE, SAVANNAH CORRINA · 2017 to 2022
$2.2M
NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA132870NCI NIH HHS R01 CA207290NCI NIH HHS R01 CA248192NCI NIH HHS U01 CA151235NCI NIH HHS U01 CA225427
6 · The paper itself

Abstract

Purpose To examine the clinical value of multiband (MB) sensitivity encoding (SENSE)-accelerated diffusion-weighted imaging (DWI) for breast imaging by performing quantitative and qualitative comparisons with conventional diffusion-weighted echo-planar imaging, or conventional DWI (cDWI). Materials and Methods In this prospective study (ClinicalTrials.gov identifier NCT03607552), women with breast cancer were recruited from July 2018 to July 2019 to undergo additional MB SENSE DWI during clinical 3-T breast MRI examinations. The cDWI and MB SENSE DWI acquisitions were assessed both quantitatively and qualitatively. Regions of interest were defined for tumorous and normal tissue, and the tumor apparent diffusion coefficient (ADC), contrast-to-noise ratio (CNR), and signal index (SI) were calculated for both DWI methods. Three readers independently reviewed the two acquisitions side by side and provided relative image quality scores. Tumor ADC, CNR, and SI measures were compared between cDWI and MB SENSE DWI acquisitions by using a paired

Indexed as

Breast NeoplasmsDiffusion Magnetic Resonance ImagingAdultAgedAged, 80 and overBreastEcho-Planar ImagingFemaleHumansMiddle AgedProspective StudiesBreastComparative StudiesMR-Diffusion-weighted ImagingTechnology Assessment

Identifiers

PMID35029517
PMCPMC8830507
OpenAlexW4206141415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.